‘When we decided to bring this show to India, Gujarat was the obvious choice’

‘When we decided to bring this show to India, Gujarat was the obvious choice’

Support from the government coupled with the advantages of being the hub of pharma and chemical industries, brings Informex to India. M Gandhi, Managing Director, UBM India, shares details with Arshiya Khan

InformexINDIA will make its debut in Ahmedabad in March, what should companies look for at InformexIndia? Can you share the details of the number of stalls, expected exhibitors, visitors, expected footfall etc?

When we decided to bring this show to India, Gujarat was the obvious choice. Gujarat is hub of chemical and pharmaceutical industries, as it accounts for 45 percent of pharmaceutical production of India. With 770 large/medium scale units and about 3,10,000 small scale units, the state houses approximately 40 percent of CROs in the country and has the highest number of Schedule M compliant manufacturing units.

We want to project that companies looking for contract manufacturing and outsourcing can directly reach and approach the clients for new tie ups and long term business relations. More then 100 exhibiting companies are expected to participate in InformexINDIA 2009 and there has been a very good number of visitors registration till date, we expect the same to cross 2,500 number of trade visitors to the show.

During the three days trade exhibition, the highlight of the event will be—international conference and Buyers-Sellers Meet organised by Pharmexcil. They have also invited FDA officials of UAE, Saudi, Kuwait, Bahrain, Oman, Syria, Jordan, Qatar, etc. for the same.

There will also be one parallel conference on chemical in general, which will be organised by reputed association ICC-Indian Chemical Council.

Do you think the global financial meltdown will have any impact on the footfall of InformexINDIA? What kind of response are you anticipating?

In the current meltdown all industries are affected but pharma is the least affected segment. Recession will not have any affect on footfall because looking at the present scenario we have designed the activities along with trade exhibition.

For pharma, Pharmexcil is organising Buyers-sellers meet by inviting regulatory officials from Middle East countries, who will explain their requirements to SMEs and guide them for the same. As it is difficult for small scale entrepreneurs to meet all these officials of 14-15 countries, this exercise will surely help understand their requirement and in turn improve their business and exports in neighbouring countries.

For chemical also we have designed a seminar and panel discussion on the current economic scenario, which will be addressed by government officials, economists, analysts and senior industrialists on the same platform. They will talk about ‘Past, Present and Future of Industry’. This will be helpful to SMEs also.

How will InformexINDIA be different from the US show?

InformexINDIA will not be much different from InformexUSA, except that the show is focused on India. We have also adjusted the show to meet the local culture.

Do you think there will be a change in the categories of exhibitors, from outsourcing which was the more prevalent trend across the pharma industry?

Since India is the hub of out sourcing, it is one of the focus areas. The reason being people from different parts of world people have shown interest in the same.

What has been the participation of trade bodies and how will it help the exhibition to become a success?

First of all this event is being organised on the invitation of the Government of Gujarat and co-organised by UBM and Government of Gujarat.

This event is supported by prominent trade associations like, CAMA (Chemical and Allied Merchant Association), Chemexcil (Basic Chemicals, Pharmaceutical and Cosmetics Export Promotion Council), ICC (Indian Chemical Council), ISCMA (Indian Specialty Chemical Manufacture Association), BDMA (Bulk Drug Manufacturers Association), IDMA (India Drug Manufacturers Association), IPA (Indian Pharmaceutical Alliance), Pharmexcil (Pharmaceutical Export Promotion Council).

They are very supportive in terms of mobilising participation at InformexINDIA 2009.

With the debut of Informex India, what are your plans for the year 2009 in terms new brand of exhibitions and events? What about PMEC and CPhI?

After the successful introduction in 2007 of ICSE trail at CPhI India, this year we have expanded the same to include an ICSE Pavilion at CPhI India. UBM is this year introducing BioPh: Bio – Solutions for Pharma. The in -licensing of new technologies from biopharmaceutical companies has become a trusted alternative method of bringing drugs to the market. All companies dealing in R&D of new treatment methods made through biotechnological processes or which are derived from or using live organisms will benefit from exhibiting at BioPh. Hosting such an event alongside ICSE, CPhI and PMEC offers unequalled networking and commercial opportunities, creating a perfect synergy in the world of drug research and manufacturing.

So far we have a very favorable response from our past exhibitors at P-MEC and CPhI. Over 50 percent of space is already booked together with 16 international companies who have confirmed their participation at PMEC India 2009 (scheduled in Mumbai Exhibition Centre, Goregaon, Mumbai from 1st to 3rd December, 2009) booking more space than the previous event.